Advanced search
Publication Cover
Journal of Medical Economics Volume 18, 2015 - Issue 10
Submit an article Journal homepage
632
Views
3
CrossRef citations to date
0
Altmetric
Original article

A network meta-analysis to compare simeprevir with boceprevir and telaprevir in combination with peginterferon-α and ribavirin in patients infected with genotype 1 Hepatitis C virus

Vanessa TaiebAmaris, London, UKCorrespondence[email protected]
,
Maud PacouAmaris, Paris, France
,
Sophia HoAmaris, London, UK
,
Ségolène PettréAmaris, London, UK
,
Suzy Van SandenJanssen EMEA, Beerse, Belgium
,
Marta PisiniJanssen EMEA, Beerse, Belgium
,
Andrew UstianowskiNorth Manchester General Hospital, Manchester, UK
&
Angelika MehnertJanssen-Cilag GmbH, Neuss, Germany
 show all
Pages 787-796 | Accepted 28 Apr 2015, Published online: 26 May 2015

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Suzy Van Sanden, Marta Pisini, Inge Duchesne, Angelika Mehnert & Jonathan Belsey. (2016) Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology. Current Medical Research and Opinion 32:1, pages 147-154.
Read now

Articles from other publishers (2)

Ariel Bardach, Akram Hernández-Vásquez, Alfredo Palacios, María Calderón, Natalie Soto, Dario Balan & Federico Augustovski. (2019) Epidemiology, Use of resources, and Costs of Medical Management of Hepatitis C in Argentina, Colombia, Uruguay, and Venezuela. Value in Health Regional Issues 20, pages 180-190.
Crossref
Helena H. Borba, Astrid Wiens, Laiza M. Steimbach, Cassio M. Perlin, Fernanda S. Tonin, Maria L. A. Pedroso, Fernando Fernandez-Llimos & Roberto Pontarolo. (2016) Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24. European Journal of Clinical Pharmacology 73:1, pages 1-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.